002311:SZSEGuangdong Haid Group Co., Limited Analysis
Data as of 2026-05-22 - not real-time
CN¥45.68
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Price action: The stock trades at 45.68 CNY, well below its 20‑day (46.99), 50‑day (49.94) and 200‑day (55.33) moving averages, signaling a bearish technical environment. The RSI of 40 and a bearish MACD histogram further reinforce short‑term downside pressure, with support anchored at the 52‑week low of 44.58 CNY.
Valuation & fundamentals: Despite the technical weakness, the DCF‑derived fair value of ~50.36 CNY implies ~42% upside, and analysts’ median target of 65.45 CNY suggests even greater upside. Revenue is growing at 13.2% YoY, ROE stands at 15.8%, and the company pays a 2.88% dividend with a 55% payout ratio, indicating sustainable cash flow. Debt is modest relative to cash (net cash positive) and beta is low (‑0.14 computed, 0.406 reported), reducing market‑wide volatility exposure.
Valuation & fundamentals: Despite the technical weakness, the DCF‑derived fair value of ~50.36 CNY implies ~42% upside, and analysts’ median target of 65.45 CNY suggests even greater upside. Revenue is growing at 13.2% YoY, ROE stands at 15.8%, and the company pays a 2.88% dividend with a 55% payout ratio, indicating sustainable cash flow. Debt is modest relative to cash (net cash positive) and beta is low (‑0.14 computed, 0.406 reported), reducing market‑wide volatility exposure.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near technical support at 44.58 CNY
- Bearish MACD and RSI indicating further downside risk
- Increasing volume suggests potential breakout but confirmation needed
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Undervalued relative to DCF fair value and analyst targets
- 13% revenue growth and solid ROE supporting earnings expansion
- Sustainable dividend yield of 2.88% with healthy payout ratio
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Stable demand for animal feed and health products in China
- Low beta and modest debt provide defensive characteristics
- Long‑term upside potential (>40%) based on valuation gap and industry positioning
Key Metrics & Analysis
Financial Health
Revenue Growth13.20%
Profit Margin2.95%
P/E Ratio19.5
ROE15.83%
ROA6.18%
Debt/Equity21.46
P/B Ratio3.0
Op. Cash FlowCN¥8.5B
Free Cash FlowCN¥3.7B
Technical Analysis
TrendBearish
RSI40.2
SupportCN¥44.58
ResistanceCN¥51.10
MA 20CN¥46.99
MA 50CN¥49.94
MA 200CN¥55.33
MACDBearish
VolumeIncreasing
Fear & Greed Index91.57
Valuation
Fair ValueCN¥50.36
Target PriceCN¥65.10
Upside/Downside42.51%
GradeUndervalued
TypeBlend
Dividend Yield2.88%
Risk Assessment
Beta-0.14
Volatility32.02%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.